Lung Cancer News

Researchers have begun enrolling patients in Pragmatica-Lung, an NCI-supported phase 3 study designed specifically to eliminate barriers to clinical trial accessibility and participation.

High incidence of lung cancer paired with stable lung cancer-related mortality rates when low-dose CT screening was introduced suggests overdiagnosis, specifically in women, according to study results published in CHEST.

As many as half of cancer-signaling proteins once thought to be resistant to drug treatment due to lack of targetability may, in fact, be treatable, a study conducted at Perelman School of Medicine at the University of Pennsylvania showed.

Delirium appeared associated with higher ICU and hospital mortality, as well as increased length of stay, among critically ill patients with cancer, according to data published in JCO Oncology Practice.

In a phase 1 trial of mistletoe extract for patients with cancer, researchers at Johns Hopkins Kimmel Cancer Center found the therapy to not only be safe but also potentially beneficial to quality of life.

In this edition, ‘paradigm shift’ in non-small cell lung cancer during past decade; osimertinib extends survival in early EGFR-mutated NSCLC; amivantamab shows durable activity in patients with advanced NSCLC, and more.

University of Chicago Medicine Comprehensive Cancer Center has joined the National Comprehensive Cancer Network as its 33rd member institution.

Social determinants of health and lack of access to specialty cancer care led to survival disparities among patients with malignant pleural mesothelioma, results of a retrospective study showed.

HHS on Monday released the National Cancer Plan, which includes eight goals and strategies to prevent cancer, reduce related mortality and improve the lives of people living with the disease.

Osimertinib extended DFS and reduced risk for recurrence among patients with resected EGFR-mutated non-small cell lung cancer, according to an updated analysis of data from the phase 3 ADAURA trial published in Journal of Clinical Oncology.